ATE320434T1 - 1-oxa-3-aza-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung - Google Patents

1-oxa-3-aza-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung

Info

Publication number: ATE320434T1
Authority: AT; Austria
Prior art keywords: production; aza; oxa; dibenzoazulene; necrosis factor
Prior art date: 2002-04-10

Application number

AT03745848T

Other languages

English (en)

Inventor

Mladen Mercep

Milan Mesic

Dijana Pesic

Iva Benko

Original Assignee

Pliva Istrazivacki Inst D O O

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-10

Filing date

2003-04-09

Publication date

2006-04-15

2003-04-09 Application filed by Pliva Istrazivacki Inst D O O filed Critical Pliva Istrazivacki Inst D O O

2006-04-15 Application granted granted Critical

2006-04-15 Publication of ATE320434T1 publication Critical patent/ATE320434T1/de

Links

238000004519 manufacturing process Methods 0.000 title abstract 4
TYGCUCNYUAIZNG-UHFFFAOYSA-N 5-oxa-3-azatetracyclo[12.4.0.02,6.08,13]octadeca-1(18),2,6,8,10,12,14,16-octaene Chemical compound O1CN=C2C3=C(C4=C(C=C12)C=CC=C4)C=CC=C3 TYGCUCNYUAIZNG-UHFFFAOYSA-N 0.000 title abstract 2
108060008682 Tumor Necrosis Factor Proteins 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
239000013067 intermediate product Substances 0.000 title 1
102000003390 tumor necrosis factor Human genes 0.000 title 1
102000000589 Interleukin-1 Human genes 0.000 abstract 2
108010002352 Interleukin-1 Proteins 0.000 abstract 2
102000009270 Tumour necrosis factor alpha Human genes 0.000 abstract 2
108050000101 Tumour necrosis factor alpha Proteins 0.000 abstract 2
230000005764 inhibitory process Effects 0.000 abstract 2
230000000202 analgesic effect Effects 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Ophthalmology & Optometry (AREA)
Toxicology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

AT03745848T 2002-04-10 2003-04-09 1-oxa-3-aza-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung ATE320434T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HR20020304A HRP20020304B1 (en)	2002-04-10	2002-04-10	1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof

Publications (1)

Publication Number	Publication Date
ATE320434T1 true ATE320434T1 (de)	2006-04-15

Family

ID=28686902

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03745848T ATE320434T1 (de)	2002-04-10	2003-04-09	1-oxa-3-aza-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung

Country Status (23)

Country	Link
US (1)	US7232815B2 (de)
EP (1)	EP1492797B1 (de)
JP (1)	JP2005529867A (de)
CN (1)	CN1649878A (de)
AT (1)	ATE320434T1 (de)
AU (1)	AU2003259960A1 (de)
BR (1)	BR0309101A (de)
CA (1)	CA2481463A1 (de)
DE (1)	DE60304047T2 (de)
DK (1)	DK1492797T3 (de)
ES (1)	ES2260636T3 (de)
HR (1)	HRP20020304B1 (de)
IL (1)	IL164397A0 (de)
IS (1)	IS7473A (de)
MX (1)	MXPA04009944A (de)
NO (1)	NO20044507L (de)
NZ (1)	NZ535621A (de)
PL (1)	PL372456A1 (de)
PT (1)	PT1492797E (de)
RU (1)	RU2323222C2 (de)
UA (1)	UA79276C2 (de)
WO (1)	WO2003084964A1 (de)
YU (1)	YU88204A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HRP20020304B1 (en) *	2002-04-10	2008-04-30	GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o.	1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
DE10256416A1 (de) *	2002-12-02	2004-06-09	Basf Ag	Feste Pigmentzubereitungen, enthaltend Pigmentderivate und oberflächenaktive Additive
HRP20030959A2 (de) *	2003-11-21	2005-10-31	Pliva-Istra�iva�ki institut d.o.o.
WO2006075255A2 (en) *	2005-01-13	2006-07-20	Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.	Anti-inflamatory macrolide conjugates

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3745167A (en) *	1968-03-19	1973-07-10	Hoffmann La Roche	3a,12b-dihydro-8h-dibenzo(3,4,6,7)cyclohept(1,2,-)oxazol-8-ones and processes for their preparation
JPS458611Y1 (de)	1969-08-18	1970-04-22
GB1340637A (en)	1971-02-05	1973-12-12	Richardson Merrell Spa	Dibenzocycloheptadioxolan derivatives
US3711489A (en) *	1971-03-31	1973-01-16	Pfizer	Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles
CA967573A (en)	1972-12-22	1975-05-13	Joseph G. Lombardino	Tetracyclic anti-inflammatory agents
US4198421A (en) *	1978-11-30	1980-04-15	E. I. Du Pont De Nemours And Company	Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles
EP0789702B1 (de) *	1994-11-02	2001-02-07	Janssen Pharmaceutica N.V.	Substituierte tetracyclische oxazepine- und thiazepinederivate mit 5-ht2 rezeptoraffinität
HRP20000310A2 (en) *	2000-05-17	2002-02-28	Pliva Farmaceutska Ind Dioniko	New dibenzoazulene compounds as tumor necrosis factor inhibitors
US20050131056A1 (en) *	2002-04-10	2005-06-16	Pliva-Istrazivacki Institut D.O.O.	2- thia-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
HRP20020305A8 (en) *	2002-04-10	2009-03-31	GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o.	2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020303B8 (en) *	2002-04-10	2009-03-31	GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o.	Benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020304B1 (en) *	2002-04-10	2008-04-30	GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o.	1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
HRP20020441A2 (en) *	2002-05-21	2003-12-31	Pliva D D	1-oxa-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20020440B1 (en) *	2002-05-21	2008-02-29	GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o.	1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
HRP20020451A2 (en) *	2002-05-23	2003-12-31	Pliva D D	1-tia-3-aza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20020453A2 (en) *	2002-05-23	2003-12-31	Pliva D D	1,3-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20030160A2 (en) *	2003-03-06	2005-04-30	Pliva-Istra�iva�ki institut d.o.o.	1-thiadibenzoazulene derivatives and biological action thereof
HRP20030885A2 (en) *	2003-11-03	2005-08-31	Pliva-Istra�iva�ki institut d.o.o.	USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS

2002
- 2002-04-10 HR HR20020304A patent/HRP20020304B1/xx not_active IP Right Cessation
2003
- 2003-04-09 YU YU88204A patent/YU88204A/sh unknown
- 2003-04-09 PL PL03372456A patent/PL372456A1/xx not_active Application Discontinuation
- 2003-04-09 PT PT03745848T patent/PT1492797E/pt unknown
- 2003-04-09 AU AU2003259960A patent/AU2003259960A1/en not_active Abandoned
- 2003-04-09 DE DE60304047T patent/DE60304047T2/de not_active Expired - Fee Related
- 2003-04-09 DK DK03745848T patent/DK1492797T3/da active
- 2003-04-09 WO PCT/HR2003/000015 patent/WO2003084964A1/en not_active Ceased
- 2003-04-09 CA CA002481463A patent/CA2481463A1/en not_active Abandoned
- 2003-04-09 BR BR0309101-5A patent/BR0309101A/pt not_active IP Right Cessation
- 2003-04-09 NZ NZ535621A patent/NZ535621A/xx unknown
- 2003-04-09 EP EP03745848A patent/EP1492797B1/de not_active Expired - Lifetime
- 2003-04-09 IL IL16439703A patent/IL164397A0/xx unknown
- 2003-04-09 CN CNA038096382A patent/CN1649878A/zh active Pending
- 2003-04-09 MX MXPA04009944A patent/MXPA04009944A/es active IP Right Grant
- 2003-04-09 ES ES03745848T patent/ES2260636T3/es not_active Expired - Lifetime
- 2003-04-09 JP JP2003582161A patent/JP2005529867A/ja active Pending
- 2003-04-09 US US10/510,620 patent/US7232815B2/en not_active Expired - Fee Related
- 2003-04-09 AT AT03745848T patent/ATE320434T1/de not_active IP Right Cessation
- 2003-04-09 RU RU2004132867/04A patent/RU2323222C2/ru not_active IP Right Cessation
- 2003-09-04 UA UA20041008545A patent/UA79276C2/uk unknown
2004
- 2004-09-27 IS IS7473A patent/IS7473A/is unknown
- 2004-10-21 NO NO20044507A patent/NO20044507L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
UA79276C2 (en)	2007-06-11
NO20044507L (no)	2004-11-09
RU2323222C2 (ru)	2008-04-27
EP1492797B1 (de)	2006-03-15
DE60304047D1 (de)	2006-05-11
ES2260636T3 (es)	2006-11-01
AU2003259960A1 (en)	2003-10-20
HRP20020304B1 (en)	2008-04-30
CA2481463A1 (en)	2003-10-16
RU2004132867A (ru)	2005-05-10
JP2005529867A (ja)	2005-10-06
WO2003084964A1 (en)	2003-10-16
DE60304047T2 (de)	2006-11-09
HRP20020304A2 (en)	2004-06-30
DK1492797T3 (da)	2006-07-17
PT1492797E (pt)	2006-07-31
IL164397A0 (en)	2005-12-18
NZ535621A (en)	2006-03-31
PL372456A1 (en)	2005-07-25
CN1649878A (zh)	2005-08-03
IS7473A (is)	2004-09-27
MXPA04009944A (es)	2005-09-30
BR0309101A (pt)	2005-02-09
US7232815B2 (en)	2007-06-19
US20050148576A1 (en)	2005-07-07
YU88204A (sh)	2006-08-17
EP1492797A1 (de)	2005-01-05

Legal Events

Date

Code

Title

Description

2007-02-15

UEP

Publication of translation of european patent specification

Ref document number: 1492797

Country of ref document: EP

2010-01-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
TW200700068A (en)	2007-01-01	Phthalazine, aza-and diaza-phthalazine compounds and methods of use
BR0316585A (pt)	2005-10-04	Derivados de ácido glioxìlico aril, ariloxi e alquiloxi 1h-indol-3-il substituìdos como inibidores do inibidor-1 do ativador do plasminogênio (pai-1)
EA200600621A1 (ru)	2006-10-27	Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
ATE469142T1 (de)	2010-06-15	Heterocyclische amid-derivate als cytokin- inhibitoren
ATE329909T1 (de)	2006-07-15	1,2,3-triazolamid-derivate als cytokininhibitoren
DE60302344D1 (de)	2005-12-22	1- oder 3-thia-benzonaphthoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung
DE60304048D1 (de)	2006-05-11	2-thia-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung
DE60304047D1 (de)	2006-05-11	1-oxa-3-aza-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung
TW200621703A (en)	2006-07-01	Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
DE602005011267D1 (de)	2009-01-08	Benzofuran- und benzothiophenderivate, die sich für die behandlung von herzkreislauferkrankungen eignen
ATE382039T1 (de)	2008-01-15	Benzimidazolone und ihre verwendung als cytokininhibitoren
EA200500326A1 (ru)	2005-06-30	Применение ферментированного экстракта проростков пшеницы в качестве противовоспалительного агента
DK1745010T3 (da)	2009-12-07	Substituerede cyklohexyl-1,4-diaminderivater
WO2003099823A3 (en)	2004-04-29	1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
WO2003097649A3 (en)	2004-04-29	1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
ATE369371T1 (de)	2007-08-15	1-azadibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung
WO2003099822A3 (en)	2005-09-29	1,2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
WO2008097953A3 (en)	2008-10-02	Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
TW200716565A (en)	2007-05-01	Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents